Publications


2015

Comprehensive genetic assessment of the ESR1 locus identifies a risk region for endometrial cancer. 

O’Mara TA, Glubb DM, Painter JN, Cheng T, Dennis J; Australian National Endometrial Cancer Study Group (ANECS), et al.


Endocr Relat Cancer
201510
https://pubmed.ncbi.nlm.nih.gov/26330482/

In Search for the Genetic Basis of Quality of Life in Healthy Swedish Women-A GWAS Study Using the iCOGS Custom Genotyping Array.

Schoormans D, Darabi H, Li J, Brandberg Y, Eriksson M, Zwinderman KH, Sprangers MA, Hall P.


PLoS One
201510

Large-scale genomic analyses link reproductive aging to hypothalamic signaling, breast cancer susceptibility and BRCA1-mediated DNA repair. 

Day FR, Ruth KS, Thompson DJ, Lunetta KL, Pervjakova N, Chasman DI, Stolk L, Finucane HK, et al.


Nat Genet
201509
https://pubmed.ncbi.nlm.nih.gov/26414677/

Fine-scale mapping of the 4q24 locus identifies two independent loci associated with breast cancer risk.

Guo X, Long J, Zeng C, Michailidou K, Ghoussaini M, Bolla MK, Wang Q, Milne RL, et al.


Cancer Epidemiol Biomarkers Prev.
201509
https://pubmed.ncbi.nlm.nih.gov/26354892/

Breast cancer tumour growth modelling for studying the association of body size with tumour growth rate and symptomatic detection using case-control data. 

Abrahamsson L, Czene K, Hall P, Humphreys K.


Breast Cancer Res
201508
https://pubmed.ncbi.nlm.nih.gov/26293658/

Height and Breast Cancer Risk: Evidence From Prospective Studies and Mendelian Randomization.

Ben Zhang, Xiao-Ou Shu, Ryan J. Delahanty, Chenjie Zeng, Kyriaki Michailidou, Manjeet K. Bolla, Qin Wang, et al.


J Natl Cancer Inst
201508
https://pubmed.ncbi.nlm.nih.gov/26296642/

A comprehensive evaluation of interaction between genetic variants and use of menopausal hormone therapy on mammographic density.

Rudolph A, Fasching PA, Behrens S, Eilber U, Bolla MK, Wang Q, Thompson D, Czene K, et al.


Breast Cancer Res
201508
https://pubmed.ncbi.nlm.nih.gov/26275715/

2014

Breast cancer genetic risk profile is differentially associated with interval and screen-detected breast cancers.

Li J, Holm J, Bergh J, Eriksson M, Darabi H, Lindström LS, Törnberg S, Hall P, et al.


Ann Oncol
201412
https://pubmed.ncbi.nlm.nih.gov/25488685/